Efficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review | Zendy

Sylvain Boet | Zendy; Cole Etherington | Zendy; George Djaiani | Zendy; Andrea C. Tricco | Zendy; Lindsey Sikora | Zendy; Rita Katznelson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review

Author(s) -

Sylvain Boet,

Cole Etherington,

George Djaiani,

Andrea C. Tricco,

Lindsey Sikora,

Rita Katznelson

Publication year - 2021

Publication title -

diving and hyperbaric medicine journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.389

H-Index - 20

eISSN - 2209-1491

pISSN - 1833-3516

DOI - 10.28920/dhm51.3.271-281

Subject(s) - medicine , mechanical ventilation , intubation , medline , adverse effect , meta analysis , randomized controlled trial , intensive care medicine , cohort study , pneumonia , covid-19 , cohort , emergency medicine , surgery , disease , political science , infectious disease (medical specialty) , law

The need for intubation and mechanical ventilation among COVID-19 patients is associated with high mortality rates and places a substantial burden on the healthcare system. There is a strong pathophysiological rationale suggesting that hyperbaric oxygen treatment (HBOT), a low-risk and non-invasive treatment, may be beneficial for COVID-19 patients. This systematic review aimed to explore the potential effectiveness and safety of HBOT for treating patients with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research